Target intelligence / Profile preview

Bacterial oxidoreductase enzyme (None established; abbreviated generally as “oxidoreductase” or by specific enzyme (e.g., “MDH” for methanol dehydrogenase), but no universal abbreviation for the broad class)

Target
None established; abbreviated generally as “oxidoreductase” or by specific enzyme (e.g., “MDH” for methanol dehydrogenase), but no universal abbreviation for the broad class
Molecular classification
Enzyme, Metabolic enzyme/protease, GMC oxidoreductase family (glucose-methanol-choline oxidoreductases), Flavin/deazaflavin oxidoreductase (FDOR), Molybdopterin oxidoreductase (DMSO family), Oxygenase, Peroxidase, Dehydrogenase, Reductase, etc., Catalase (heme and non-heme), Classified by EC number: EC 1.x.x.x
01

Overview

Bacterial oxidoreductase enzymes are a diverse group of enzymes (classified in EC 1) that catalyze redox reactions—electron transfer between molecules—essential for cellular metabolism, energy production, and detoxification in bacteria. They comprise various families (dehydrogenases, reductases, oxidases, peroxidases, oxygenases, catalases) and show wide structural and mechanistic diversity, employing cofactors such as NAD/NADP, FMN, FAD, Heme, or metal ions. They are widespread in bacterial species, with some subclasses unique to bacteria or archaea (e.g., certain Mn-catalases and DMSO/molybdopterin oxidoreductases). Their functional roles include core metabolism, adaptation to stress, and, in some bacteria, alternative energy production. As therapeutic targets, they are recognized for roles in infection (bacterial viability and antibiotic resistance), and as industrial biocatalysts, they are valued for oxidation, reduction, and detoxification processes under extreme conditions. The term is an umbrella for hundreds of distinct enzymes, each with specialized substrates, cofactors, and disease or biotechnology importance.

Other names
OxidoreductaseRedox enzymeDehydrogenase (when O₂ is not acceptor)ReductaseOxidase (when O₂ is acceptor)EC 1 enzymes (Enzyme Commission class)Specific names by substrate (e.g., Alcohol dehydrogenase, Glucose oxidase, Catalase, Monoamine oxidase, Peroxidase)
02

Mechanism of action

Inhibition of electron transfer/metabolic pathway activity; Generation of reactive oxygen species (ROS); Interference with substrate binding or cofactor utilization (NAD/NADP, FMN, FAD, Heme, Iron-sulfur cluster); Modification or destruction of bacterial energy metabolism

03

Biological functions

Electron transfer (redox reactions)Cellular respirationMetabolism of carbohydrates, amino acids, lipids, xenobioticsDetoxification (e.g., degradation of reactive oxygen species)Energy production (particularly in bacteria lacking cytochrome bc complexes)Biosynthesis of cofactorsBiotechnological catalysis
04

Disease associations

Infection (roles in pathogen metabolism and antibiotic resistance)Inflammation (redox state regulation)Other: Oxidative stress-associated conditions, biotechnology enzyme applications, metabolic disorders (when mutated in bacteria)
05

Safety considerations

Off-target toxicity: Inhibitors may affect human homologs or gut microbiota oxidoreductasesRedox imbalance: Unintended modulation may promote oxidative stress—the therapeutic window is often tight.Resistance development in bacteria: Especially with antibiotics targeting redox enzymes.Biotechnological challenges: Stability, activity under industrial conditions, supply chain (noted for extremophilic oxidoreductases)
06

Interacting drugs

Antibiotics (modulating oxidoreductase enzymes in pathogens)

2 more in the full profile.

07

Biomarkers

Enzyme activity assays for specific oxidoreductases (e.g., NADH dehydrogenase activity)Metabolic profiling for redox balance or oxidative stressPresence of oxidoreductase gene/protein in pathogens (diagnostic PCR or proteomics)Specific biomarkers exist for individual enzymes, not for the broad class.

Beyond the preview

Go deeper on Bacterial oxidoreductase enzyme (None established; abbreviated generally as “oxidoreductase” or by specific enzyme (e.g., “MDH” for methanol dehydrogenase), but no universal abbreviation for the broad class).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial oxidoreductase enzyme (None established; abbreviated generally as “oxidoreductase” or by specific enzyme (e.g., “MDH” for methanol dehydrogenase), but no universal abbreviation for the broad class).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call